Filing Details

Accession Number:
0000891293-17-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-02 17:25:03
Reporting Period:
2017-09-28
Accepted Time:
2017-10-02 17:25:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201041 L Richard Love 3101 Western Avenue
Suite 600
Seattle WA 98121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-28 4,000 $3.19 84,318 No 4 S Direct
Common Stock Disposition 2017-09-28 700 $3.20 83,618 No 4 S Direct
Common Stock Disposition 2017-09-28 2,747 $3.20 80,871 No 4 S Direct
Common Stock Disposition 2017-09-28 200 $3.21 80,671 No 4 S Direct
Common Stock Disposition 2017-09-28 100 $3.21 80,571 No 4 S Direct
Common Stock Disposition 2017-09-28 1,000 $3.21 79,571 No 4 S Direct
Common Stock Disposition 2017-09-28 100 $3.22 79,471 No 4 S Direct
Common Stock Disposition 2017-09-28 600 $3.22 78,871 No 4 S Direct
Common Stock Disposition 2017-09-28 25 $3.23 78,846 No 4 S Direct
Common Stock Disposition 2017-09-28 1,675 $3.23 77,171 No 4 S Direct
Common Stock Disposition 2017-09-28 1,600 $3.23 75,571 No 4 S Direct
Common Stock Disposition 2017-09-28 200 $3.24 75,371 No 4 S Direct
Common Stock Disposition 2017-09-28 477 $3.24 74,894 No 4 S Direct
Common Stock Disposition 2017-09-28 200 $3.25 74,694 No 4 S Direct
Common Stock Disposition 2017-09-29 976 $3.20 73,718 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct